nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A4—Thiotepa—urinary bladder cancer	0.0682	0.256	CbGbCtD
Oxybutynin—CYP2C8—Fluorouracil—urinary bladder cancer	0.0546	0.205	CbGbCtD
Oxybutynin—CYP3A5—Etoposide—urinary bladder cancer	0.0474	0.178	CbGbCtD
Oxybutynin—CYP2C8—Etoposide—urinary bladder cancer	0.0456	0.171	CbGbCtD
Oxybutynin—CHRM3—ureter—urinary bladder cancer	0.0409	0.286	CbGeAlD
Oxybutynin—CHRM3—muscle of abdomen—urinary bladder cancer	0.0295	0.206	CbGeAlD
Oxybutynin—CYP2D6—Doxorubicin—urinary bladder cancer	0.0198	0.0743	CbGbCtD
Oxybutynin—CYP3A4—Etoposide—urinary bladder cancer	0.0185	0.0693	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0126	0.0473	CbGbCtD
Oxybutynin—CYP3A4—urine—urinary bladder cancer	0.0073	0.0511	CbGeAlD
Oxybutynin—CYP2D6—urine—urinary bladder cancer	0.00719	0.0502	CbGeAlD
Oxybutynin—CHRM5—epithelium—urinary bladder cancer	0.00627	0.0438	CbGeAlD
Oxybutynin—CHRM2—prostate gland—urinary bladder cancer	0.00586	0.0409	CbGeAlD
Oxybutynin—CHRM1—prostate gland—urinary bladder cancer	0.00533	0.0373	CbGeAlD
Oxybutynin—CHRM3—prostate gland—urinary bladder cancer	0.00477	0.0334	CbGeAlD
Oxybutynin—CYP3A5—prostate gland—urinary bladder cancer	0.00349	0.0244	CbGeAlD
Oxybutynin—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00338	0.0236	CbGeAlD
Oxybutynin—CHRM3—renal system—urinary bladder cancer	0.00325	0.0227	CbGeAlD
Oxybutynin—CHRM3—urethra—urinary bladder cancer	0.00319	0.0223	CbGeAlD
Oxybutynin—CHRM1—female reproductive system—urinary bladder cancer	0.00291	0.0203	CbGeAlD
Oxybutynin—CYP2C8—renal system—urinary bladder cancer	0.00264	0.0184	CbGeAlD
Oxybutynin—CHRM3—female reproductive system—urinary bladder cancer	0.0026	0.0182	CbGeAlD
Oxybutynin—CYP3A5—renal system—urinary bladder cancer	0.00238	0.0166	CbGeAlD
Oxybutynin—CYP2C8—female reproductive system—urinary bladder cancer	0.00211	0.0148	CbGeAlD
Oxybutynin—CYP2C8—vagina—urinary bladder cancer	0.00191	0.0134	CbGeAlD
Oxybutynin—CYP3A4—renal system—urinary bladder cancer	0.00179	0.0125	CbGeAlD
Oxybutynin—CYP2D6—renal system—urinary bladder cancer	0.00176	0.0123	CbGeAlD
Oxybutynin—CYP3A5—vagina—urinary bladder cancer	0.00172	0.0121	CbGeAlD
Oxybutynin—CYP3A4—female reproductive system—urinary bladder cancer	0.00143	0.01	CbGeAlD
Oxybutynin—CYP2D6—female reproductive system—urinary bladder cancer	0.00141	0.00985	CbGeAlD
Oxybutynin—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000345	0.000655	CcSEcCtD
Oxybutynin—Asthenia—Gemcitabine—urinary bladder cancer	0.000344	0.000653	CcSEcCtD
Oxybutynin—Haematuria—Epirubicin—urinary bladder cancer	0.000343	0.000652	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000343	0.000651	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000341	0.000647	CcSEcCtD
Oxybutynin—Epistaxis—Epirubicin—urinary bladder cancer	0.00034	0.000645	CcSEcCtD
Oxybutynin—Pruritus—Gemcitabine—urinary bladder cancer	0.000339	0.000644	CcSEcCtD
Oxybutynin—Nausea—Thiotepa—urinary bladder cancer	0.000339	0.000643	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—urinary bladder cancer	0.000339	0.000643	CcSEcCtD
Oxybutynin—Sinusitis—Epirubicin—urinary bladder cancer	0.000338	0.000641	CcSEcCtD
Oxybutynin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000338	0.000641	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000335	0.000636	CcSEcCtD
Oxybutynin—Pruritus—Fluorouracil—urinary bladder cancer	0.000334	0.000633	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000333	0.000632	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—urinary bladder cancer	0.000333	0.000632	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000333	0.000632	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—urinary bladder cancer	0.000333	0.000632	CcSEcCtD
Oxybutynin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000329	0.000625	CcSEcCtD
Oxybutynin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000328	0.000623	CcSEcCtD
Oxybutynin—Urticaria—Etoposide—urinary bladder cancer	0.000325	0.000618	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000325	0.000616	CcSEcCtD
Oxybutynin—Rhinitis—Epirubicin—urinary bladder cancer	0.000324	0.000615	CcSEcCtD
Oxybutynin—Abdominal pain—Etoposide—urinary bladder cancer	0.000324	0.000615	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000324	0.000615	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000324	0.000615	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—urinary bladder cancer	0.000323	0.000613	CcSEcCtD
Oxybutynin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000323	0.000613	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—urinary bladder cancer	0.000322	0.000611	CcSEcCtD
Oxybutynin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000322	0.00061	CcSEcCtD
Oxybutynin—Asthenia—Cisplatin—urinary bladder cancer	0.000321	0.000609	CcSEcCtD
Oxybutynin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000321	0.000609	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000321	0.000608	CcSEcCtD
Oxybutynin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000319	0.000606	CcSEcCtD
Oxybutynin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000318	0.000604	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—urinary bladder cancer	0.000318	0.000603	CcSEcCtD
Oxybutynin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000318	0.000603	CcSEcCtD
Oxybutynin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000317	0.000601	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000314	0.000596	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—urinary bladder cancer	0.000313	0.000595	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000313	0.000593	CcSEcCtD
Oxybutynin—Dizziness—Fluorouracil—urinary bladder cancer	0.000312	0.000592	CcSEcCtD
Oxybutynin—Visual impairment—Epirubicin—urinary bladder cancer	0.000311	0.000591	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000311	0.000591	CcSEcCtD
Oxybutynin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000306	0.000581	CcSEcCtD
Oxybutynin—Vomiting—Gemcitabine—urinary bladder cancer	0.000305	0.000579	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—urinary bladder cancer	0.000303	0.000574	CcSEcCtD
Oxybutynin—Rash—Gemcitabine—urinary bladder cancer	0.000302	0.000574	CcSEcCtD
Oxybutynin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000302	0.000574	CcSEcCtD
Oxybutynin—Eye disorder—Epirubicin—urinary bladder cancer	0.000302	0.000573	CcSEcCtD
Oxybutynin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000302	0.000573	CcSEcCtD
Oxybutynin—Tinnitus—Epirubicin—urinary bladder cancer	0.000301	0.000572	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—urinary bladder cancer	0.000301	0.000571	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—urinary bladder cancer	0.000301	0.000571	CcSEcCtD
Oxybutynin—Headache—Gemcitabine—urinary bladder cancer	0.000301	0.000571	CcSEcCtD
Oxybutynin—Flushing—Epirubicin—urinary bladder cancer	0.0003	0.000569	CcSEcCtD
Oxybutynin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.0003	0.000569	CcSEcCtD
Oxybutynin—Vomiting—Fluorouracil—urinary bladder cancer	0.0003	0.000569	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—urinary bladder cancer	0.0003	0.000569	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000298	0.000565	CcSEcCtD
Oxybutynin—Rash—Fluorouracil—urinary bladder cancer	0.000297	0.000565	CcSEcCtD
Oxybutynin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000297	0.000564	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000297	0.000563	CcSEcCtD
Oxybutynin—Headache—Fluorouracil—urinary bladder cancer	0.000295	0.000561	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000295	0.000561	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000295	0.000559	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000294	0.000559	CcSEcCtD
Oxybutynin—Asthenia—Etoposide—urinary bladder cancer	0.000294	0.000558	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000294	0.000558	CcSEcCtD
Oxybutynin—Angiopathy—Epirubicin—urinary bladder cancer	0.000293	0.000557	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000293	0.000556	CcSEcCtD
Oxybutynin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000291	0.000553	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—urinary bladder cancer	0.000291	0.000552	CcSEcCtD
Oxybutynin—Pruritus—Etoposide—urinary bladder cancer	0.00029	0.00055	CcSEcCtD
Oxybutynin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000289	0.000548	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000288	0.000547	CcSEcCtD
Oxybutynin—Nausea—Gemcitabine—urinary bladder cancer	0.000285	0.000541	CcSEcCtD
Oxybutynin—Vomiting—Cisplatin—urinary bladder cancer	0.000284	0.00054	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—urinary bladder cancer	0.000283	0.000538	CcSEcCtD
Oxybutynin—Mental disorder—Epirubicin—urinary bladder cancer	0.000283	0.000538	CcSEcCtD
Oxybutynin—Rash—Cisplatin—urinary bladder cancer	0.000282	0.000535	CcSEcCtD
Oxybutynin—Dermatitis—Cisplatin—urinary bladder cancer	0.000282	0.000535	CcSEcCtD
Oxybutynin—Malnutrition—Epirubicin—urinary bladder cancer	0.000281	0.000534	CcSEcCtD
Oxybutynin—Erythema—Epirubicin—urinary bladder cancer	0.000281	0.000534	CcSEcCtD
Oxybutynin—Diarrhoea—Etoposide—urinary bladder cancer	0.00028	0.000532	CcSEcCtD
Oxybutynin—Nausea—Fluorouracil—urinary bladder cancer	0.00028	0.000532	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000279	0.000531	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000279	0.00053	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000279	0.000529	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000278	0.000527	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—urinary bladder cancer	0.000278	0.000527	CcSEcCtD
Oxybutynin—Flatulence—Epirubicin—urinary bladder cancer	0.000277	0.000526	CcSEcCtD
Oxybutynin—Tension—Epirubicin—urinary bladder cancer	0.000276	0.000524	CcSEcCtD
Oxybutynin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000276	0.000523	CcSEcCtD
Oxybutynin—Nervousness—Epirubicin—urinary bladder cancer	0.000273	0.000519	CcSEcCtD
Oxybutynin—Back pain—Epirubicin—urinary bladder cancer	0.000272	0.000517	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000271	0.000515	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—urinary bladder cancer	0.000271	0.000515	CcSEcCtD
Oxybutynin—Dizziness—Etoposide—urinary bladder cancer	0.000271	0.000514	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00027	0.000512	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000267	0.000507	CcSEcCtD
Oxybutynin—Nausea—Cisplatin—urinary bladder cancer	0.000266	0.000504	CcSEcCtD
Oxybutynin—Vision blurred—Epirubicin—urinary bladder cancer	0.000265	0.000503	CcSEcCtD
Oxybutynin—Cough—Methotrexate—urinary bladder cancer	0.000262	0.000498	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000262	0.000497	CcSEcCtD
Oxybutynin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000261	0.000496	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—urinary bladder cancer	0.00026	0.000494	CcSEcCtD
Oxybutynin—Vomiting—Etoposide—urinary bladder cancer	0.00026	0.000494	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—urinary bladder cancer	0.00026	0.000494	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—urinary bladder cancer	0.00026	0.000494	CcSEcCtD
Oxybutynin—Agitation—Epirubicin—urinary bladder cancer	0.000259	0.000491	CcSEcCtD
Oxybutynin—Rash—Etoposide—urinary bladder cancer	0.000258	0.00049	CcSEcCtD
Oxybutynin—Dermatitis—Etoposide—urinary bladder cancer	0.000258	0.00049	CcSEcCtD
Oxybutynin—Headache—Etoposide—urinary bladder cancer	0.000257	0.000487	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—urinary bladder cancer	0.000257	0.000487	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—urinary bladder cancer	0.000256	0.000486	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—urinary bladder cancer	0.000256	0.000486	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—urinary bladder cancer	0.000255	0.000485	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000255	0.000484	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000254	0.000483	CcSEcCtD
Oxybutynin—Malaise—Epirubicin—urinary bladder cancer	0.000254	0.000482	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—urinary bladder cancer	0.000253	0.00048	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—urinary bladder cancer	0.000253	0.00048	CcSEcCtD
Oxybutynin—Syncope—Epirubicin—urinary bladder cancer	0.000252	0.000479	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—urinary bladder cancer	0.000252	0.000478	CcSEcCtD
Oxybutynin—Palpitations—Epirubicin—urinary bladder cancer	0.000249	0.000472	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—urinary bladder cancer	0.000247	0.00047	CcSEcCtD
Oxybutynin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000247	0.000469	CcSEcCtD
Oxybutynin—Cough—Epirubicin—urinary bladder cancer	0.000246	0.000466	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000245	0.000466	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000245	0.000466	CcSEcCtD
Oxybutynin—Convulsion—Epirubicin—urinary bladder cancer	0.000244	0.000463	CcSEcCtD
Oxybutynin—Infection—Methotrexate—urinary bladder cancer	0.000244	0.000463	CcSEcCtD
Oxybutynin—Nausea—Etoposide—urinary bladder cancer	0.000243	0.000462	CcSEcCtD
Oxybutynin—Hypertension—Epirubicin—urinary bladder cancer	0.000243	0.000461	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000242	0.000459	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000241	0.000457	CcSEcCtD
Oxybutynin—Arthralgia—Epirubicin—urinary bladder cancer	0.00024	0.000455	CcSEcCtD
Oxybutynin—Chest pain—Epirubicin—urinary bladder cancer	0.00024	0.000455	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—urinary bladder cancer	0.000239	0.000454	CcSEcCtD
Oxybutynin—Anxiety—Epirubicin—urinary bladder cancer	0.000239	0.000453	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—urinary bladder cancer	0.000238	0.000452	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000238	0.000452	CcSEcCtD
Oxybutynin—Discomfort—Epirubicin—urinary bladder cancer	0.000237	0.000449	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—urinary bladder cancer	0.000235	0.000446	CcSEcCtD
Oxybutynin—Dry mouth—Epirubicin—urinary bladder cancer	0.000234	0.000445	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—urinary bladder cancer	0.000234	0.000444	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—urinary bladder cancer	0.000233	0.000443	CcSEcCtD
Oxybutynin—Confusional state—Epirubicin—urinary bladder cancer	0.000232	0.00044	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—urinary bladder cancer	0.00023	0.000437	CcSEcCtD
Oxybutynin—Oedema—Epirubicin—urinary bladder cancer	0.00023	0.000436	CcSEcCtD
Oxybutynin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00023	0.000436	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—urinary bladder cancer	0.000229	0.000435	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000229	0.000434	CcSEcCtD
Oxybutynin—Infection—Epirubicin—urinary bladder cancer	0.000228	0.000433	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—urinary bladder cancer	0.000227	0.000431	CcSEcCtD
Oxybutynin—Shock—Epirubicin—urinary bladder cancer	0.000226	0.000429	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—urinary bladder cancer	0.000226	0.000428	CcSEcCtD
Oxybutynin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000225	0.000427	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—urinary bladder cancer	0.000225	0.000427	CcSEcCtD
Oxybutynin—Tachycardia—Epirubicin—urinary bladder cancer	0.000224	0.000425	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000224	0.000424	CcSEcCtD
Oxybutynin—Skin disorder—Epirubicin—urinary bladder cancer	0.000223	0.000423	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—urinary bladder cancer	0.000222	0.000421	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000222	0.000421	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—urinary bladder cancer	0.000222	0.000421	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—urinary bladder cancer	0.000221	0.000419	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—urinary bladder cancer	0.00022	0.000418	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00022	0.000418	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—urinary bladder cancer	0.000219	0.000416	CcSEcCtD
Oxybutynin—Anorexia—Epirubicin—urinary bladder cancer	0.000219	0.000416	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—urinary bladder cancer	0.000218	0.000414	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000217	0.000411	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000216	0.00041	CcSEcCtD
Oxybutynin—Hypotension—Epirubicin—urinary bladder cancer	0.000215	0.000407	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—urinary bladder cancer	0.000214	0.000407	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000213	0.000405	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000212	0.000403	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—urinary bladder cancer	0.000212	0.000403	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000212	0.000402	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—urinary bladder cancer	0.000212	0.000402	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—urinary bladder cancer	0.000211	0.000401	CcSEcCtD
Oxybutynin—Pain—Methotrexate—urinary bladder cancer	0.00021	0.000398	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000209	0.000397	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—urinary bladder cancer	0.000209	0.000397	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000208	0.000396	CcSEcCtD
Oxybutynin—Insomnia—Epirubicin—urinary bladder cancer	0.000208	0.000394	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000207	0.000394	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000206	0.000392	CcSEcCtD
Oxybutynin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000206	0.000391	CcSEcCtD
Oxybutynin—Somnolence—Epirubicin—urinary bladder cancer	0.000204	0.000388	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—urinary bladder cancer	0.000203	0.000384	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000202	0.000384	CcSEcCtD
Oxybutynin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000202	0.000384	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000201	0.000381	CcSEcCtD
Oxybutynin—Decreased appetite—Epirubicin—urinary bladder cancer	0.0002	0.000379	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—urinary bladder cancer	0.000199	0.000377	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000198	0.000376	CcSEcCtD
Oxybutynin—Fatigue—Epirubicin—urinary bladder cancer	0.000198	0.000376	CcSEcCtD
Oxybutynin—Constipation—Epirubicin—urinary bladder cancer	0.000196	0.000373	CcSEcCtD
Oxybutynin—Pain—Epirubicin—urinary bladder cancer	0.000196	0.000373	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—urinary bladder cancer	0.000195	0.00037	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000194	0.000368	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000194	0.000367	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—urinary bladder cancer	0.000192	0.000365	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000191	0.000362	CcSEcCtD
Oxybutynin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000189	0.000359	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—urinary bladder cancer	0.000189	0.000359	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000188	0.000356	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000187	0.000355	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000185	0.000351	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000183	0.000348	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—urinary bladder cancer	0.000183	0.000348	CcSEcCtD
Oxybutynin—Urticaria—Epirubicin—urinary bladder cancer	0.000182	0.000346	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—urinary bladder cancer	0.000182	0.000345	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—urinary bladder cancer	0.000182	0.000345	CcSEcCtD
Oxybutynin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000182	0.000345	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000181	0.000343	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—urinary bladder cancer	0.000176	0.000334	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000175	0.000332	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000174	0.00033	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—urinary bladder cancer	0.000174	0.00033	CcSEcCtD
Oxybutynin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000169	0.000321	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—urinary bladder cancer	0.000169	0.00032	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000168	0.000319	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000168	0.000319	CcSEcCtD
Oxybutynin—Asthenia—Epirubicin—urinary bladder cancer	0.000165	0.000313	CcSEcCtD
Oxybutynin—Pruritus—Epirubicin—urinary bladder cancer	0.000162	0.000308	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—urinary bladder cancer	0.000162	0.000308	CcSEcCtD
Oxybutynin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000157	0.000298	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000157	0.000297	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—urinary bladder cancer	0.000156	0.000296	CcSEcCtD
Oxybutynin—Rash—Methotrexate—urinary bladder cancer	0.000155	0.000294	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—urinary bladder cancer	0.000155	0.000293	CcSEcCtD
Oxybutynin—Headache—Methotrexate—urinary bladder cancer	0.000154	0.000292	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—urinary bladder cancer	0.000152	0.000289	CcSEcCtD
Oxybutynin—Dizziness—Epirubicin—urinary bladder cancer	0.000152	0.000288	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—urinary bladder cancer	0.00015	0.000285	CcSEcCtD
Oxybutynin—Vomiting—Epirubicin—urinary bladder cancer	0.000146	0.000277	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—urinary bladder cancer	0.000146	0.000277	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000145	0.000276	CcSEcCtD
Oxybutynin—Rash—Epirubicin—urinary bladder cancer	0.000145	0.000275	CcSEcCtD
Oxybutynin—Dermatitis—Epirubicin—urinary bladder cancer	0.000145	0.000275	CcSEcCtD
Oxybutynin—Headache—Epirubicin—urinary bladder cancer	0.000144	0.000273	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—urinary bladder cancer	0.00014	0.000267	CcSEcCtD
Oxybutynin—Nausea—Epirubicin—urinary bladder cancer	0.000136	0.000259	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—urinary bladder cancer	0.000135	0.000256	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—urinary bladder cancer	0.000134	0.000254	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000134	0.000254	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—urinary bladder cancer	0.000133	0.000253	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—urinary bladder cancer	0.000126	0.00024	CcSEcCtD
Oxybutynin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.45e-05	0.000703	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—RRM2—urinary bladder cancer	4.28e-05	0.000675	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—TP53—urinary bladder cancer	4.25e-05	0.000671	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TSC1—urinary bladder cancer	4.21e-05	0.000664	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.21e-05	0.000664	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	4.17e-05	0.000658	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.1e-05	0.000647	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—JAG1—urinary bladder cancer	4.01e-05	0.000632	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4e-05	0.000632	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.99e-05	0.00063	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ENO2—urinary bladder cancer	3.96e-05	0.000625	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—HPGDS—urinary bladder cancer	3.96e-05	0.000625	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	3.86e-05	0.000608	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTT1—urinary bladder cancer	3.84e-05	0.000606	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	3.84e-05	0.000606	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.83e-05	0.000605	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.73e-05	0.000589	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	3.7e-05	0.000584	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—CXCL8—urinary bladder cancer	3.69e-05	0.000582	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—CXCL8—urinary bladder cancer	3.66e-05	0.000577	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.61e-05	0.00057	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.6e-05	0.000568	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.54e-05	0.000558	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.54e-05	0.000558	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—RHOA—urinary bladder cancer	3.39e-05	0.000534	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	3.33e-05	0.000526	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	3.33e-05	0.000526	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.28e-05	0.000517	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—S100B—urinary bladder cancer	3.24e-05	0.000512	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.23e-05	0.00051	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3.23e-05	0.00051	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—NQO1—urinary bladder cancer	3.19e-05	0.000504	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RBX1—urinary bladder cancer	3.15e-05	0.000497	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RBX1—urinary bladder cancer	3.14e-05	0.000496	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	3.12e-05	0.000492	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RBX1—urinary bladder cancer	3.11e-05	0.000491	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—RHOA—urinary bladder cancer	3.08e-05	0.000485	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.97e-05	0.000469	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.96e-05	0.000468	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TSC1—urinary bladder cancer	2.96e-05	0.000467	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TSC1—urinary bladder cancer	2.95e-05	0.000466	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TSC1—urinary bladder cancer	2.92e-05	0.000461	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NCOR1—urinary bladder cancer	2.92e-05	0.00046	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.91e-05	0.000459	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.89e-05	0.000455	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.89e-05	0.000455	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.87e-05	0.000453	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—IL2—urinary bladder cancer	2.84e-05	0.000448	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JAG1—urinary bladder cancer	2.82e-05	0.000445	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JAG1—urinary bladder cancer	2.81e-05	0.000444	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.8e-05	0.000442	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JAG1—urinary bladder cancer	2.78e-05	0.000439	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.76e-05	0.000435	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.75e-05	0.000434	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—CXCL8—urinary bladder cancer	2.7e-05	0.000426	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.69e-05	0.000424	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.68e-05	0.000423	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTP1—urinary bladder cancer	2.66e-05	0.00042	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL2—urinary bladder cancer	2.58e-05	0.000407	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TERT—urinary bladder cancer	2.57e-05	0.000406	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.56e-05	0.000404	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—TYMS—urinary bladder cancer	2.48e-05	0.000391	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—NCOR1—urinary bladder cancer	2.45e-05	0.000386	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTM1—urinary bladder cancer	2.45e-05	0.000386	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.38e-05	0.000376	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—RHOA—urinary bladder cancer	2.38e-05	0.000375	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.37e-05	0.000374	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.37e-05	0.000374	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—FGFR3—urinary bladder cancer	2.36e-05	0.000372	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—RHOA—urinary bladder cancer	2.35e-05	0.000371	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GPX1—urinary bladder cancer	2.34e-05	0.00037	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.33e-05	0.000367	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ERCC2—urinary bladder cancer	2.3e-05	0.000363	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.3e-05	0.000363	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ESR1—urinary bladder cancer	2.29e-05	0.000361	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—S100B—urinary bladder cancer	2.28e-05	0.00036	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—S100B—urinary bladder cancer	2.28e-05	0.000359	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.26e-05	0.000356	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—S100B—urinary bladder cancer	2.25e-05	0.000356	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.24e-05	0.000353	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—RHOA—urinary bladder cancer	2.17e-05	0.000342	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—MTHFR—urinary bladder cancer	2.16e-05	0.000341	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—RHOA—urinary bladder cancer	2.16e-05	0.00034	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.14e-05	0.000338	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—RHOA—urinary bladder cancer	2.14e-05	0.000337	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.09e-05	0.00033	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.09e-05	0.000329	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.08e-05	0.000329	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.07e-05	0.000326	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.06e-05	0.000325	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.06e-05	0.000325	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NCOR1—urinary bladder cancer	2.05e-05	0.000324	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NCOR1—urinary bladder cancer	2.05e-05	0.000323	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NCOR1—urinary bladder cancer	2.03e-05	0.00032	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CREBBP—urinary bladder cancer	2.01e-05	0.000317	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—IL2—urinary bladder cancer	2e-05	0.000316	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—IL2—urinary bladder cancer	1.99e-05	0.000315	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IGF1—urinary bladder cancer	1.98e-05	0.000313	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—IL2—urinary bladder cancer	1.97e-05	0.000312	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EGFR—urinary bladder cancer	1.97e-05	0.000311	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.97e-05	0.000311	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.97e-05	0.000311	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.94e-05	0.000306	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.94e-05	0.000306	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.94e-05	0.000305	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.91e-05	0.000301	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.9e-05	0.0003	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCL8—urinary bladder cancer	1.89e-05	0.000299	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.88e-05	0.000296	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCL8—urinary bladder cancer	1.88e-05	0.000296	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—KRAS—urinary bladder cancer	1.86e-05	0.000294	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.82e-05	0.000287	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RHOA—urinary bladder cancer	1.82e-05	0.000287	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL2—urinary bladder cancer	1.82e-05	0.000287	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL2—urinary bladder cancer	1.81e-05	0.000286	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TERT—urinary bladder cancer	1.81e-05	0.000286	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TERT—urinary bladder cancer	1.8e-05	0.000285	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.8e-05	0.000285	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL2—urinary bladder cancer	1.79e-05	0.000283	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TERT—urinary bladder cancer	1.79e-05	0.000282	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.78e-05	0.000281	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.78e-05	0.000281	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARG—urinary bladder cancer	1.75e-05	0.000277	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.71e-05	0.000269	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CREBBP—urinary bladder cancer	1.69e-05	0.000266	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ERBB2—urinary bladder cancer	1.68e-05	0.000265	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.68e-05	0.000264	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.67e-05	0.000264	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FGFR3—urinary bladder cancer	1.66e-05	0.000262	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FGFR3—urinary bladder cancer	1.66e-05	0.000261	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FGFR3—urinary bladder cancer	1.64e-05	0.000259	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ESR1—urinary bladder cancer	1.61e-05	0.000254	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ESR1—urinary bladder cancer	1.61e-05	0.000254	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL8—urinary bladder cancer	1.59e-05	0.000252	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.59e-05	0.000251	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ESR1—urinary bladder cancer	1.59e-05	0.000251	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HRAS—urinary bladder cancer	1.58e-05	0.00025	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.58e-05	0.000249	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.55e-05	0.000244	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.55e-05	0.000244	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL2—urinary bladder cancer	1.52e-05	0.00024	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.5e-05	0.000237	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—urinary bladder cancer	1.49e-05	0.000234	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.48e-05	0.000234	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.48e-05	0.000233	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.46e-05	0.000231	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.46e-05	0.000231	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—urinary bladder cancer	1.44e-05	0.000228	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1A—urinary bladder cancer	1.44e-05	0.000227	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTEN—urinary bladder cancer	1.43e-05	0.000226	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.42e-05	0.000224	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CREBBP—urinary bladder cancer	1.41e-05	0.000223	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CREBBP—urinary bladder cancer	1.41e-05	0.000222	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.4e-05	0.000221	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF1—urinary bladder cancer	1.4e-05	0.00022	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CREBBP—urinary bladder cancer	1.4e-05	0.00022	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF1—urinary bladder cancer	1.39e-05	0.00022	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—urinary bladder cancer	1.39e-05	0.000219	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—urinary bladder cancer	1.38e-05	0.000218	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—urinary bladder cancer	1.38e-05	0.000218	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF1—urinary bladder cancer	1.38e-05	0.000217	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.38e-05	0.000217	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—urinary bladder cancer	1.37e-05	0.000216	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EP300—urinary bladder cancer	1.37e-05	0.000216	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SRC—urinary bladder cancer	1.33e-05	0.00021	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—urinary bladder cancer	1.31e-05	0.000207	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—urinary bladder cancer	1.31e-05	0.000206	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	1.3e-05	0.000204	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.29e-05	0.000204	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RHOA—urinary bladder cancer	1.28e-05	0.000202	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.28e-05	0.000202	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RHOA—urinary bladder cancer	1.28e-05	0.000201	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	1.26e-05	0.000199	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.25e-05	0.000197	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.23e-05	0.000194	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTEN—urinary bladder cancer	1.2e-05	0.00019	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—urinary bladder cancer	1.19e-05	0.000188	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	1.18e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	1.18e-05	0.000186	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	1.17e-05	0.000184	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—urinary bladder cancer	1.17e-05	0.000184	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.16e-05	0.000183	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—EP300—urinary bladder cancer	1.15e-05	0.000181	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	1.12e-05	0.000177	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	1.12e-05	0.000177	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	1.12e-05	0.000176	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	1.11e-05	0.000175	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	1.11e-05	0.000175	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	1.1e-05	0.000174	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—urinary bladder cancer	1.1e-05	0.000174	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	1.07e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	1.07e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	1.06e-05	0.000167	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.05e-05	0.000166	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	1.05e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	1.04e-05	0.000165	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.04e-05	0.000164	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	1.03e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	1.02e-05	0.00016	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	1.01e-05	0.00016	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.01e-05	0.00016	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.01e-05	0.00016	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	1.01e-05	0.000159	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.01e-05	0.000159	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.01e-05	0.000159	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	1.01e-05	0.000159	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.000159	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	1e-05	0.000158	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	9.99e-06	0.000158	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	9.97e-06	0.000157	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—urinary bladder cancer	9.79e-06	0.000154	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.68e-06	0.000153	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—EP300—urinary bladder cancer	9.65e-06	0.000152	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	9.63e-06	0.000152	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	9.6e-06	0.000151	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.57e-06	0.000151	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.57e-06	0.000151	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	9.51e-06	0.00015	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	9.36e-06	0.000148	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HRAS—urinary bladder cancer	9.36e-06	0.000148	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	9.33e-06	0.000147	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	9.24e-06	0.000146	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.17e-06	0.000145	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9e-06	0.000142	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	8.77e-06	0.000138	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.46e-06	0.000133	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	8.39e-06	0.000132	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	8.36e-06	0.000132	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—EP300—urinary bladder cancer	8.36e-06	0.000132	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	8.28e-06	0.000131	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	8.25e-06	0.00013	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	8.21e-06	0.000129	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	8.18e-06	0.000129	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	8.1e-06	0.000128	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	7.75e-06	0.000122	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	7.73e-06	0.000122	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	7.65e-06	0.000121	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	7.2e-06	0.000114	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	6.89e-06	0.000109	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	6.87e-06	0.000108	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.86e-06	0.000108	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.86e-06	0.000108	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	6.8e-06	0.000107	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	6.59e-06	0.000104	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.59e-06	0.000104	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	6.57e-06	0.000104	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	6.51e-06	0.000103	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.4e-06	8.51e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.71e-06	7.42e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.49e-06	7.08e-05	CbGpPWpGaD
